FR2849376B1 - Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique - Google Patents

Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique

Info

Publication number
FR2849376B1
FR2849376B1 FR0216873A FR0216873A FR2849376B1 FR 2849376 B1 FR2849376 B1 FR 2849376B1 FR 0216873 A FR0216873 A FR 0216873A FR 0216873 A FR0216873 A FR 0216873A FR 2849376 B1 FR2849376 B1 FR 2849376B1
Authority
FR
France
Prior art keywords
polynucleotide
nucleotide
peptide
protein
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0216873A
Other languages
English (en)
Other versions
FR2849376A1 (fr
Inventor
Jean Noel Thorel
Cerard Redziniak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0216873A priority Critical patent/FR2849376B1/fr
Application filed by Individual filed Critical Individual
Priority to PCT/FR2003/003883 priority patent/WO2004060393A2/fr
Priority to AU2003303607A priority patent/AU2003303607A1/en
Priority to EP03814486.1A priority patent/EP1581177B1/fr
Priority to JP2004564302A priority patent/JP4249710B2/ja
Priority to US10/537,816 priority patent/US20060029563A1/en
Priority to CA2528101A priority patent/CA2528101C/fr
Priority to ES03814486.1T priority patent/ES2668072T3/es
Priority to KR1020057012464A priority patent/KR101007637B1/ko
Publication of FR2849376A1 publication Critical patent/FR2849376A1/fr
Application granted granted Critical
Publication of FR2849376B1 publication Critical patent/FR2849376B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
FR0216873A 2002-12-30 2002-12-30 Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique Expired - Lifetime FR2849376B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0216873A FR2849376B1 (fr) 2002-12-30 2002-12-30 Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique
AU2003303607A AU2003303607A1 (en) 2002-12-30 2003-12-23 Cutaneous metabolic bio-activator
EP03814486.1A EP1581177B1 (fr) 2002-12-30 2003-12-23 Bio-activateur metabolique cutane
JP2004564302A JP4249710B2 (ja) 2002-12-30 2003-12-23 皮膚代謝生理活性物質
PCT/FR2003/003883 WO2004060393A2 (fr) 2002-12-30 2003-12-23 Activateur cutane associant de l’atp avec d’autres bio-molecules a effet metabolique.
US10/537,816 US20060029563A1 (en) 2002-12-30 2003-12-23 Cutanceous metabolic bio-activator
CA2528101A CA2528101C (fr) 2002-12-30 2003-12-23 Bio-activateur metabolique cutane
ES03814486.1T ES2668072T3 (es) 2002-12-30 2003-12-23 Bioactivador metabólico cutáneo
KR1020057012464A KR101007637B1 (ko) 2002-12-30 2003-12-23 피부 대사 생체 활성제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216873A FR2849376B1 (fr) 2002-12-30 2002-12-30 Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique

Publications (2)

Publication Number Publication Date
FR2849376A1 FR2849376A1 (fr) 2004-07-02
FR2849376B1 true FR2849376B1 (fr) 2007-07-13

Family

ID=32480299

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0216873A Expired - Lifetime FR2849376B1 (fr) 2002-12-30 2002-12-30 Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique

Country Status (1)

Country Link
FR (1) FR2849376B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006036082A1 (fr) * 2004-09-06 2006-04-06 Obschestvo S Ogranichennoy Otvetstvennostyu 'sankt-Peterburgsky Institut Krasoty' Produit cosmetique et procede de fabrication correspondant
CN112915042A (zh) * 2021-03-23 2021-06-08 沈阳方方苷肽科技发展有限公司 核苷酸大豆多肽组合物与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590169B1 (fr) * 1985-11-20 1991-03-15 Secta Labo Cosmetologie Y Roch Composition cosmetique contenant des bio-stimulines
US5254331A (en) * 1991-09-12 1993-10-19 Chanel, Inc. Skin cream composition
DE4139639A1 (de) * 1991-12-02 1993-06-03 Schuelke & Mayr Gmbh Waessrige synthetische organextrakte
US5885974A (en) * 1994-12-06 1999-03-23 Michael M. Danielov Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
US6444647B1 (en) * 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
FR2801787B1 (fr) * 1999-12-01 2002-03-01 Robert Louis Prugnaud Nouvelles compositions cosmetiques pour ameliorer l'elasticite des tissus de soutien
MXPA01006553A (es) * 1999-12-14 2002-03-14 Avon Prod Inc Composicion pare el cuidado de la piel que media la comunicacion de celula a celula. .

Also Published As

Publication number Publication date
FR2849376A1 (fr) 2004-07-02

Similar Documents

Publication Publication Date Title
IL166531A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
WO2002022821A3 (fr) Peptides antimicrobiens et methodes d'utilisation
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
DE69935314D1 (de) Quantitatitative bestimmung von nucleinsäure-amplifizierungsprodukten
MA28976B1 (fr) Multimeres d'oligonucleotides immunostimulateurs
WO2002044320A3 (fr) Genes humains de l'elongase, leurs utilisations et composes destines a leur modulation
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
FR2840217B1 (fr) Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations
WO2004094476A3 (fr) Compositions et methodes se rapportant a stop-1
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
EP0979309A4 (fr) Oligonucleotides presentant une meilleure biodisponibilite
WO2003029422A3 (fr) Gene du syndrome de noonan
FR2751222B1 (fr) Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
FR2849376B1 (fr) Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique
WO2003054167A3 (fr) Identification de sites polymorphes dans le gene humain mglur8 et utilisations associees
IL158293A (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
WO2006122971A3 (fr) Traitement de maladies a l'aide d'un systeme d'expression regulee, ameliore
WO1999031253A3 (fr) Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations
WO2002062964A3 (fr) Variants d'amine oxydase ap1
WO2002072632A3 (fr) Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations
WO2003082206A3 (fr) Proteines derivees de l'immunoglobuline liees a la sclerose en plaques, compositions, methodes et utilisations relatives
IL164326A0 (en) Nucleic acid and corresponding protein entitled 238p1b2 and pharmaceutical compositions containing the same
WO2001014415A3 (fr) Gènes egfh2 et produits géniques
WO2001018061A3 (fr) Polynucleotides et polypeptides associes extraits du mais utilises pour renforcer la resistance aux maladies des plantes cultivees
UA91178C2 (ru) Мутантный неубластин

Legal Events

Date Code Title Description
TP Transmission of property
AU Other action affecting the ownership or exploitation of an industrial property right
CL Concession to grant licences
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20